Thanks mate, time lines!
What we can expect in the coming weeks and quarter. Q4 - starting in October and running through to December
is going to be huge for this company. There is sooo much coming up in terms of Trial Results, the big ticket items are;
Phase 2 b Sleep Apnoea results for the Total Addressable Market (TAM) of US$5.95 BLN Per Annum
IHL-675A (Wonder Drug) Phase 1 Human Trials with a TAM of US$125 BLN Per Annum
Stage 2 Traumatic Brian Injury (TBI)
Plus more....
![https://hotcopper.com.au/data/attachments/3564/3564969-ea6ff3c167739a19c6cb3f9ac90a1d4e.jpg](https://hotcopper.com.au/data/attachments/3564/3564969-ea6ff3c167739a19c6cb3f9ac90a1d4e.jpg)
Before end of this month, still anticipating more news regarding NASDAQ listing activities also notification from the FDA regarding a date in Q4 for the Psi-GAD Pre-Ind meeting.
Good luck
@Greenwave17